IGH (14q32) Break probe hybridized to patient material showing a partial deletion of 14q32 (1RG1R).
IGH (14q32) Break probe hybridized to patient material showing a partial deletion of 14q32 (1RG1R).
IVD IGH Break
Multiple myeloma is characterized by complex rearrangements involving the IgH gene, particularly at the constant locus. The IgH rearrangement provides a useful marker of clonality in B-cell malignancies and amplification of this rearrangement is the method of choice to monitor the residual tumor cells in multiple myeloma. The IGH (14q32) break probe is optimized to detect translocations involving the IGH gene region at 14q32 in a dual-color, split assay.
References: Taniwaki et al, 1994, Blood, 83; 2962-1969. Gozetti et al, 2002, Cancer Research, 62; 5523-5527.
产品
产品
KBI-10601
IGH (14q32) Break
Product is out of stock
Due to manufacturing & supply chain issues, this product is currently unavailable. You may place your order and it will be fulfilled when the product is back in stock. For more help, please reach out to customer service at +1 844 534 2262 or nonurgentcs@leicabiosystems.com
Product is limited in stock
Product availability is limited, but products are in continuous production. Your order will be processed as normal and may take additional days to ship.
HK
